Understanding phase transitions in pharmaceutical materials is of vital importance for drug manufacturing, processing and storage. In this paper we have carried out comprehensive high-resolution spectroscopic studies on the polymorphs of the non-steroidal anti-inflammatory drug diflunisal that has four known polymorphs, forms I–IV (FI–FIV), three of which have known crystal structures. Phase transformations during milling, heating, melt-quenching and exposure to high relative humidity were investigated using Raman and terahertz spectroscopy in combination with differential scanning calorimetry and X-ray powder diffraction. The observed phase transformations indicate the stability order FIII > FI > FII, FIV. Furthermore, crystallization experiments from the gas phase and from solution by fast evaporation of different solvents were carried out. Fast evaporation of an ethanolic solution below 70 °C was identified as a reliable and convenient method to obtain the somewhat elusive FII in bulk quantities.
|Number of pages||10|
|Journal||International Journal of Pharmaceutics|
|Early online date||8 Jun 2017|
|Publication status||Published - Aug 2017|
- Phase transformation
- Terahertz spectroscopy
ASJC Scopus subject areas
- Pharmaceutical Science
FingerprintDive into the research topics of 'A comprehensive spectroscopic study of the polymorphs of diflunisal and their phase transformations'. Together they form a unique fingerprint.
High Performance Computing (HPC) Facility
Steven Chapman (Manager)University of Bath